Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19
In a live conversation on Facebook and Twitter, Dr. Collins and NHLBI Director Dr. Gary Gibbons discuss the launch of Phase 3 clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.
This page last reviewed on